Page last updated: 2024-08-24

sipatrigine and Anterior Circulation Transient Ischemic Attack

sipatrigine has been researched along with Anterior Circulation Transient Ischemic Attack in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (80.00)18.2507
2000's1 (20.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dewar, D; McCracken, E; McCulloch, J1
Daly, D; Durant, GJ; Fischer, JB; Goldin, SM; Hu, LY; Knapp, AG; Magar, S; Reddy, NL; Sharma, R; Subbarao, K1
Leach, MJ; Swan, JH1
Graham, SH; Kawaguchi, K1
Henshall, DC; Kawaguchi, K; Simon, RP1

Reviews

1 review(s) available for sipatrigine and Anterior Circulation Transient Ischemic Attack

ArticleYear
Neuroprotective use-dependent blockers of Na+ and Ca2+ channels controlling presynaptic release of glutamate.
    Annals of the New York Academy of Sciences, 1995, Sep-15, Volume: 765

    Topics: Animals; Blood Pressure; Brain; Calcium Channel Blockers; CHO Cells; Cricetinae; Electrophysiology; Glutamic Acid; Guanidines; Heart Rate; Ischemic Attack, Transient; Kinetics; Neuroprotective Agents; Neurotransmitter Uptake Inhibitors; Piperazines; Pyrimidines; Rats; Receptors, N-Methyl-D-Aspartate; Recombinant Proteins; Sodium Channel Blockers; Sodium Channels

1995

Other Studies

4 other study(ies) available for sipatrigine and Anterior Circulation Transient Ischemic Attack

ArticleYear
Sipatrigine and oligodendrocyte and axonal pathology following transient focal cerebral ischaemia in the rat.
    Neuroreport, 2003, Mar-03, Volume: 14, Issue:3

    Topics: Animals; Axons; Ischemic Attack, Transient; Male; Neurons; Neuroprotective Agents; Oligodendroglia; Piperazines; Pyrimidines; Rats; Rats, Sprague-Dawley

2003
Evaluation of the novel neuroprotective agent BW619C89 in the middle cerebral artery occlusion model of focal ischemia in the spontaneously hypertensive rat and normotensive Fischer 344 rat.
    Annals of the New York Academy of Sciences, 1995, Sep-15, Volume: 765

    Topics: Animals; Caudate Nucleus; Cerebral Arteries; Cerebral Infarction; Hippocampus; Ischemic Attack, Transient; Neuroprotective Agents; Piperazines; Pyrimidines; Rats; Rats, Inbred F344; Rats, Inbred SHR; Species Specificity

1995
Neuroprotective effects of the glutamate release inhibitor 619C89 in temporary middle cerebral artery occlusion.
    Brain research, 1997, Feb-21, Volume: 749, Issue:1

    Topics: Animals; Blood Gas Analysis; Cerebral Arteries; Cerebral Infarction; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Ischemic Attack, Transient; Male; Neostriatum; Neuroprotective Agents; Piperazines; Pyrimidines; Rats; Rats, Sprague-Dawley; Reperfusion Injury

1997
Parallel dose-response studies of the voltage-dependent Na+ channel antagonist BW619C89, and the voltage-dependent Ca2+ channel antagonist nimodipine, in rat transient focal cerebral ischaemia.
    European journal of pharmacology, 1999, Jan-08, Volume: 364, Issue:2-3

    Topics: Animals; Blood Glucose; Blood Pressure; Body Temperature; Brain; Calcium Channel Blockers; Dose-Response Relationship, Drug; Electric Stimulation; Hydrogen-Ion Concentration; Ischemic Attack, Transient; Male; Neuroprotective Agents; Nimodipine; Piperazines; Pyrimidines; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Sodium Channel Blockers

1999